You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alum

Showing 1 - 25 of 199
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial in Linköping (GAD-alum (Diamyd) 40 µg/mL)

Recruiting
  • Diabetes Mellitus, Type 1
  • GAD-alum (Diamyd) 40 μg/mL
  • Linköping, Sweden
    Kliniska Forskningsenheten (Hudmottagningen), Universitetssjukhu
Aug 17, 2022

HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

Recruiting
  • HIV-1-infection
  • INO-6160, 2 mg
  • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
  • New York, New York
  • +2 more
Apr 13, 2023

Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)

Not yet recruiting
  • Chronic HIV Infection
  • 426c.Mod.Core-C4b
  • Adjuvant 3M-052-AF+Alum
  • Birmingham, Alabama
  • +6 more
Aug 17, 2023

COVID-19 (Healthy Volunteers) Trial in Korea, Republic of (GBP510 adjuvanted with Alum (RBD 10µg/dose) - Stage 1, Normal saline

Active, not recruiting
  • COVID-19 (Healthy Volunteers)
  • GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 1
  • +5 more
  • Ansan, Korea, Republic of
  • +11 more
May 9, 2022

Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active

Completed
  • Type I Diabetes
  • Placebo GABA and Placebo GAD-alum
  • +2 more
  • Birmingham, Alabama
    Children's of Alabama
May 2, 2022

COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • SARS-CoV-2 inactivated vaccine
  • Semarang, Central Java, Indonesia
  • +1 more
Aug 8, 2022

HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine

Recruiting
  • HIV Infections
  • Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
  • +3 more
  • Columbus, Ohio
  • +1 more
Apr 10, 2022

Lyme Borreliosis, Nervous System Trial in La Mesa, Lincoln, Ghent (VLA15 with Alum, VLA15 without Alum)

Completed
  • Lyme Borreliosis, Nervous System
  • VLA15 with Alum
  • VLA15 without Alum
  • La Mesa, California
  • +2 more
Dec 16, 2022

COVID-19 Trial in Kyiv, Vinnitsa (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline)

Terminated
  • COVID-19
  • CpG 1018/Alum-adjuvanted SCB-2019 vaccine
  • +2 more
  • Kyiv, Ukraine
  • +3 more
May 19, 2022

Chikungunya Virus Trial in Lenexa (CHIKV VLP, adjuvanted)

Completed
  • Chikungunya Virus
  • CHIKV VLP, adjuvanted
  • Lenexa, Kansas
    Johnson County ClinTrials
Jul 18, 2022

Zika Virus Infection Trial in Ponce (Placebo, Zika Virus Purified Inactivated Vaccine (ZPIV))

Completed
  • Zika Virus Infection
  • Placebo
  • Zika Virus Purified Inactivated Vaccine (ZPIV)
  • Ponce, Puerto Rico
    Ponce School of Medicine CAIMED Center
Apr 5, 2022

Chikungunya Trial in Fort Deterick, Silver Spring (Chikungunya)

Completed
  • Chikungunya
  • Chikungunya
  • Fort Deterick, Maryland
  • +1 more
Jan 4, 2022

Human Immunodeficiency Virus Prevention, Human Immunodeficiency Virus (HIV) Trial run by the NIAID (VRC-HIVRGP096-00-VP, Alum

Completed
Has Results
  • Human Immunodeficiency Virus Prevention
  • Human Immunodeficiency Virus (HIV)
  • VRC-HIVRGP096-00-VP
  • Alum Adjuvant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 6, 2021

COVID-19 (Healthy Volunteers) Trial in Seongnam-si, Seoul (NBP2001 adjuvanted with alum (RBD 30µg/dose), NBP2001 adjuvanted with

Active, not recruiting
  • COVID-19 (Healthy Volunteers)
  • NBP2001 adjuvanted with alum (RBD 30μg/dose)
  • +2 more
  • Seongnam-si, Bundang, Korea, Republic of
  • +1 more
May 9, 2022

COVID-19 Trial in Nedlands (SCB-2019, SCB-2019 with AS03 adjuvant, SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant)

Completed
  • COVID-19
  • SCB-2019
  • +3 more
  • Nedlands, Western Australia, Australia
    Linear Clinical Research Ltd
Feb 17, 2022

HIV-1-infection Trial in United States (426c.Mod.Core-C4b 30 mcg, 426c.Mod.Core-C4b 100 mcg, 426c.Mod.Core-C4b 300 mcg)

Recruiting
  • HIV-1-infection
  • 426c.Mod.Core-C4b 30 mcg
  • +3 more
  • Birmingham, Alabama
  • +5 more
Jul 25, 2022

HIV Trial in Birmingham, Rochester, Seattle (rgp120/HIV-1MN)

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • Birmingham, Alabama
  • +2 more
Oct 27, 2021

Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
  • (no location specified)
May 8, 2023

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +3 more
Oct 28, 2021

COVID-19 Trial in Barranquilla, Cali (Candidate vaccine, SCB-2019)

Not yet recruiting
  • COVID-19
  • Candidate vaccine, SCB-2019
  • Barranquilla, Colombia
  • +1 more
Aug 23, 2022

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +4 more
Oct 28, 2021

HIV Trial in United States (MN rgp120/HIV-1, TBC-3B Vaccine)

Completed
  • HIV Infections
  • MN rgp120/HIV-1
  • TBC-3B Vaccine
  • Baltimore, Maryland
  • +3 more
Oct 27, 2021

COVID-19 Trial in Bloemfontein, Pretoria, Soweto (Candidate vaccine, SCB-2020S, Candidate vaccine, SCB-2019, Squalene based

Active, not recruiting
  • COVID-19
  • Candidate vaccine, SCB-2020S
  • +3 more
  • Bloemfontein, South Africa
  • +2 more
Oct 18, 2022

Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
  • Amsterdam, Netherlands
    The Amsterdam University Medical Centers
Aug 2, 2023

HIV Trial in United States (rgp120/HIV-1MN, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +6 more
Oct 28, 2021